- Home
- YCBD vs SSY Comparison
YCBD vs SSY Comparison
Compare YCBD & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- SSY
- Stock Information
- Founded
- YCBD 2015
- SSY 1959
- Country
- YCBD United States
- SSY United States
- Employees
- YCBD N/A
- SSY N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- YCBD Health Care
- SSY Health Care
- Exchange
- YCBD Nasdaq
- SSY Nasdaq
- Market Cap
- YCBD 7.8M
- SSY 6.8M
- IPO Year
- YCBD N/A
- SSY N/A
- Fundamental
- Price
- YCBD $0.95
- SSY $1.36
- Analyst Decision
- YCBD Strong Buy
- SSY
- Analyst Count
- YCBD 1
- SSY 0
- Target Price
- YCBD $3.00
- SSY N/A
- AVG Volume (30 Days)
- YCBD 67.8K
- SSY 200.2K
- Earning Date
- YCBD 08-13-2025
- SSY 05-13-2025
- Dividend Yield
- YCBD N/A
- SSY 7.35%
- EPS Growth
- YCBD N/A
- SSY N/A
- EPS
- YCBD N/A
- SSY 0.25
- Revenue
- YCBD $19,593,146.00
- SSY $31,094,000.00
- Revenue This Year
- YCBD $13.00
- SSY N/A
- Revenue Next Year
- YCBD $10.00
- SSY N/A
- P/E Ratio
- YCBD N/A
- SSY $5.55
- Revenue Growth
- YCBD N/A
- SSY N/A
- 52 Week Low
- YCBD $0.76
- SSY $0.62
- 52 Week High
- YCBD $6.54
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- YCBD 51.65
- SSY 79.08
- Support Level
- YCBD $0.90
- SSY $1.12
- Resistance Level
- YCBD $0.99
- SSY $1.36
- Average True Range (ATR)
- YCBD 0.06
- SSY 0.12
- MACD
- YCBD 0.01
- SSY 0.03
- Stochastic Oscillator
- YCBD 58.90
- SSY 93.18
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.